Phase I Multicentre Tax-Torc Trial of the Dual Mtorc1/2 Inhibitor Azd2014 (A) Plus Weekly Paclitaxel (P) in Patients (Pts) with Solid Tumours (Crukd/12/013)

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Annals of oncology 2014-09, Vol.25, p.iv156
Hauptverfasser: Basu, B., Roda-Perez, D., Wong, H.H., Sathiyayogan, N., Parmar, M., Turner, A., Swales, K., Stimpson, S., Hall, E., Hategan, M., Garcia-Corbacho, J., Yap, T.A., Molife, L.R., Jimenez, B., Banerjee, S., Kaye, S.B., De Bono, J.S., Banerji, U.
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page iv156
container_title Annals of oncology
container_volume 25
creator Basu, B.
Roda-Perez, D.
Wong, H.H.
Sathiyayogan, N.
Parmar, M.
Turner, A.
Swales, K.
Stimpson, S.
Hall, E.
Hategan, M.
Garcia-Corbacho, J.
Yap, T.A.
Molife, L.R.
Jimenez, B.
Banerjee, S.
Kaye, S.B.
De Bono, J.S.
Banerji, U.
description
doi_str_mv 10.1093/annonc/mdu331.28
format Article
fullrecord <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_1093_annonc_mdu331_28</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_1093_annonc_mdu331_28</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1308-8afc11bf0cd75f96532a840e6a5b827091acfe103dff128ed5f57d35af79eb423</originalsourceid><addsrcrecordid>eNotkMtKw0AUhmehYK3uXZ5lu0gzl6RJlqXeCi0GjLgMk7mQsdNEZibY-iw-rJG6Ov8F_gMfQncELwguWMy7ru9EfJADY2RB8ws0wQVlUZay5Apde_-BMV4WtJign7LlXsEGdoMNRqguOAUVP0ZV7wRUznALvYbQKrgfRr0LY05iCpuuNY0ZHay-JcUkgdlqDqUdPLwrtbcnKLmwJvCjsjAr52C6MQlm_OBHH_wcvkxo4bW3RkI1HPrBjcXaDXsZExpjwuY36FJz69Xt_52it8eHav0cbV-eNuvVNhKE4TzKuRaENBoLmaW6WKaM8jzBasnTJqcZLggXWhHMpNaE5kqmOs0kS7nOCtUklE0RPu8K13vvlK4_nTlwd6oJrv-I1mei9ZloTXP2CyG5bCs</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Phase I Multicentre Tax-Torc Trial of the Dual Mtorc1/2 Inhibitor Azd2014 (A) Plus Weekly Paclitaxel (P) in Patients (Pts) with Solid Tumours (Crukd/12/013)</title><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Basu, B. ; Roda-Perez, D. ; Wong, H.H. ; Sathiyayogan, N. ; Parmar, M. ; Turner, A. ; Swales, K. ; Stimpson, S. ; Hall, E. ; Hategan, M. ; Garcia-Corbacho, J. ; Yap, T.A. ; Molife, L.R. ; Jimenez, B. ; Banerjee, S. ; Kaye, S.B. ; De Bono, J.S. ; Banerji, U.</creator><creatorcontrib>Basu, B. ; Roda-Perez, D. ; Wong, H.H. ; Sathiyayogan, N. ; Parmar, M. ; Turner, A. ; Swales, K. ; Stimpson, S. ; Hall, E. ; Hategan, M. ; Garcia-Corbacho, J. ; Yap, T.A. ; Molife, L.R. ; Jimenez, B. ; Banerjee, S. ; Kaye, S.B. ; De Bono, J.S. ; Banerji, U.</creatorcontrib><identifier>ISSN: 0923-7534</identifier><identifier>DOI: 10.1093/annonc/mdu331.28</identifier><language>eng</language><ispartof>Annals of oncology, 2014-09, Vol.25, p.iv156</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c1308-8afc11bf0cd75f96532a840e6a5b827091acfe103dff128ed5f57d35af79eb423</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids></links><search><creatorcontrib>Basu, B.</creatorcontrib><creatorcontrib>Roda-Perez, D.</creatorcontrib><creatorcontrib>Wong, H.H.</creatorcontrib><creatorcontrib>Sathiyayogan, N.</creatorcontrib><creatorcontrib>Parmar, M.</creatorcontrib><creatorcontrib>Turner, A.</creatorcontrib><creatorcontrib>Swales, K.</creatorcontrib><creatorcontrib>Stimpson, S.</creatorcontrib><creatorcontrib>Hall, E.</creatorcontrib><creatorcontrib>Hategan, M.</creatorcontrib><creatorcontrib>Garcia-Corbacho, J.</creatorcontrib><creatorcontrib>Yap, T.A.</creatorcontrib><creatorcontrib>Molife, L.R.</creatorcontrib><creatorcontrib>Jimenez, B.</creatorcontrib><creatorcontrib>Banerjee, S.</creatorcontrib><creatorcontrib>Kaye, S.B.</creatorcontrib><creatorcontrib>De Bono, J.S.</creatorcontrib><creatorcontrib>Banerji, U.</creatorcontrib><title>Phase I Multicentre Tax-Torc Trial of the Dual Mtorc1/2 Inhibitor Azd2014 (A) Plus Weekly Paclitaxel (P) in Patients (Pts) with Solid Tumours (Crukd/12/013)</title><title>Annals of oncology</title><issn>0923-7534</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><recordid>eNotkMtKw0AUhmehYK3uXZ5lu0gzl6RJlqXeCi0GjLgMk7mQsdNEZibY-iw-rJG6Ov8F_gMfQncELwguWMy7ru9EfJADY2RB8ws0wQVlUZay5Apde_-BMV4WtJign7LlXsEGdoMNRqguOAUVP0ZV7wRUznALvYbQKrgfRr0LY05iCpuuNY0ZHay-JcUkgdlqDqUdPLwrtbcnKLmwJvCjsjAr52C6MQlm_OBHH_wcvkxo4bW3RkI1HPrBjcXaDXsZExpjwuY36FJz69Xt_52it8eHav0cbV-eNuvVNhKE4TzKuRaENBoLmaW6WKaM8jzBasnTJqcZLggXWhHMpNaE5kqmOs0kS7nOCtUklE0RPu8K13vvlK4_nTlwd6oJrv-I1mei9ZloTXP2CyG5bCs</recordid><startdate>201409</startdate><enddate>201409</enddate><creator>Basu, B.</creator><creator>Roda-Perez, D.</creator><creator>Wong, H.H.</creator><creator>Sathiyayogan, N.</creator><creator>Parmar, M.</creator><creator>Turner, A.</creator><creator>Swales, K.</creator><creator>Stimpson, S.</creator><creator>Hall, E.</creator><creator>Hategan, M.</creator><creator>Garcia-Corbacho, J.</creator><creator>Yap, T.A.</creator><creator>Molife, L.R.</creator><creator>Jimenez, B.</creator><creator>Banerjee, S.</creator><creator>Kaye, S.B.</creator><creator>De Bono, J.S.</creator><creator>Banerji, U.</creator><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>201409</creationdate><title>Phase I Multicentre Tax-Torc Trial of the Dual Mtorc1/2 Inhibitor Azd2014 (A) Plus Weekly Paclitaxel (P) in Patients (Pts) with Solid Tumours (Crukd/12/013)</title><author>Basu, B. ; Roda-Perez, D. ; Wong, H.H. ; Sathiyayogan, N. ; Parmar, M. ; Turner, A. ; Swales, K. ; Stimpson, S. ; Hall, E. ; Hategan, M. ; Garcia-Corbacho, J. ; Yap, T.A. ; Molife, L.R. ; Jimenez, B. ; Banerjee, S. ; Kaye, S.B. ; De Bono, J.S. ; Banerji, U.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1308-8afc11bf0cd75f96532a840e6a5b827091acfe103dff128ed5f57d35af79eb423</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Basu, B.</creatorcontrib><creatorcontrib>Roda-Perez, D.</creatorcontrib><creatorcontrib>Wong, H.H.</creatorcontrib><creatorcontrib>Sathiyayogan, N.</creatorcontrib><creatorcontrib>Parmar, M.</creatorcontrib><creatorcontrib>Turner, A.</creatorcontrib><creatorcontrib>Swales, K.</creatorcontrib><creatorcontrib>Stimpson, S.</creatorcontrib><creatorcontrib>Hall, E.</creatorcontrib><creatorcontrib>Hategan, M.</creatorcontrib><creatorcontrib>Garcia-Corbacho, J.</creatorcontrib><creatorcontrib>Yap, T.A.</creatorcontrib><creatorcontrib>Molife, L.R.</creatorcontrib><creatorcontrib>Jimenez, B.</creatorcontrib><creatorcontrib>Banerjee, S.</creatorcontrib><creatorcontrib>Kaye, S.B.</creatorcontrib><creatorcontrib>De Bono, J.S.</creatorcontrib><creatorcontrib>Banerji, U.</creatorcontrib><collection>CrossRef</collection><jtitle>Annals of oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Basu, B.</au><au>Roda-Perez, D.</au><au>Wong, H.H.</au><au>Sathiyayogan, N.</au><au>Parmar, M.</au><au>Turner, A.</au><au>Swales, K.</au><au>Stimpson, S.</au><au>Hall, E.</au><au>Hategan, M.</au><au>Garcia-Corbacho, J.</au><au>Yap, T.A.</au><au>Molife, L.R.</au><au>Jimenez, B.</au><au>Banerjee, S.</au><au>Kaye, S.B.</au><au>De Bono, J.S.</au><au>Banerji, U.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Phase I Multicentre Tax-Torc Trial of the Dual Mtorc1/2 Inhibitor Azd2014 (A) Plus Weekly Paclitaxel (P) in Patients (Pts) with Solid Tumours (Crukd/12/013)</atitle><jtitle>Annals of oncology</jtitle><date>2014-09</date><risdate>2014</risdate><volume>25</volume><spage>iv156</spage><pages>iv156-</pages><issn>0923-7534</issn><doi>10.1093/annonc/mdu331.28</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0923-7534
ispartof Annals of oncology, 2014-09, Vol.25, p.iv156
issn 0923-7534
language eng
recordid cdi_crossref_primary_10_1093_annonc_mdu331_28
source EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
title Phase I Multicentre Tax-Torc Trial of the Dual Mtorc1/2 Inhibitor Azd2014 (A) Plus Weekly Paclitaxel (P) in Patients (Pts) with Solid Tumours (Crukd/12/013)
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-17T17%3A21%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Phase%20I%20Multicentre%20Tax-Torc%20Trial%20of%20the%20Dual%20Mtorc1/2%20Inhibitor%20Azd2014%20(A)%20Plus%20Weekly%20Paclitaxel%20(P)%20in%20Patients%20(Pts)%20with%20Solid%20Tumours%20(Crukd/12/013)&rft.jtitle=Annals%20of%20oncology&rft.au=Basu,%20B.&rft.date=2014-09&rft.volume=25&rft.spage=iv156&rft.pages=iv156-&rft.issn=0923-7534&rft_id=info:doi/10.1093/annonc/mdu331.28&rft_dat=%3Ccrossref%3E10_1093_annonc_mdu331_28%3C/crossref%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true